MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer.

MLA

Ji-hong Pan, et al. “MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer.” Respiration, vol. 78, no. 1, July 2009, pp. 49–55. EBSCOhost, https://doi.org/10.1159/000158454.

APA

Ji-hong Pan, Jin-xiang Han, Jian-mei Wu, Hai-nan Huang, Qing-zhong Yu, & Li-jun Sheng. (2009). MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer. Respiration, 78(1), 49–55. https://doi.org/10.1159/000158454

Chicago

Ji-hong Pan, Jin-xiang Han, Jian-mei Wu, Hai-nan Huang, Qing-zhong Yu, and Li-jun Sheng. 2009. “MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer.” Respiration 78 (1): 49–55. doi:10.1159/000158454.